MIM
SMMT icon

MetLife Investment Management’s Summit Therapeutics SMMT Stock Holding History

MetLife Investment Management’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$136K Sell
7,186
-358
-5% -$5.79K ﹤0.01% 2401
2025
Q4 		$132K Buy
7,544
+66
+0.9% +$1.24K ﹤0.01% 2475
2025
Q3 		$154K Buy
7,478
+215
+3% +$5.21K ﹤0.01% 2455
2025
Q2 		$155K Sell
7,263
-47,428
-87% -$1.08M ﹤0.01% 2316
2025
Q1 		$1.05M Sell
54,691
-715
-1% -$14.3K 0.01% 1338
2024
Q4 		$989K Buy
55,406
+3,981
+8% +$77.2K 0.01% 1420
2024
Q3 		$1.13M Hold
51,425
– – 0.01% 1331
2024
Q2 		$401K Sell
51,425
-11,893
-19% -$64.2K ﹤0.01% 1846
2024
Q1 		$262K Hold
63,318
– – ﹤0.01% 2044
2023
Q4 		$165K Hold
63,318
– – ﹤0.01% 2344
2023
Q3 		$118K Hold
63,318
– – ﹤0.01% 2494
2023
Q2 		$159K Buy
+63,318
New +$116K ﹤0.01% 2407

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return